BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190430
DTEND;VALUE=DATE:20190502
DTSTAMP:20260514T214546
CREATED:20190110T103553Z
LAST-MODIFIED:20190110T110108Z
UID:18984-1556582400-1556755199@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials to the West Coast 2019
DESCRIPTION:Arena International is excited to announce the return of the 6th Annual Clinical Operations in Oncology Trials to the West Coast on April 30th – May 1st 2019. \nAs one of the only oncology operationally focused events in the West Coast\, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage West Coast physicians and patients. \nThe event will be led by a myriad of industry specialists from the West Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion\, spotlight Q&As\, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market. \nWhile maintaining the primary focus of its previous years\, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry\, and provide insight into the latest technological and therapeutic solutions. \nWe hope to see you in April\, make sure to register your place today!
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials-to-the-west-coast-2019/
LOCATION:Burlingame\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190509
DTSTAMP:20260514T214546
CREATED:20190201T151752Z
LAST-MODIFIED:20190201T151752Z
UID:19366-1557100800-1557359999@www.pharmajournalist.com
SUMMARY:2nd Annual CKD3 Summit
DESCRIPTION:Chronic Kidney Disease Drug Development (CKD3) is a uniquely focused conference that unites key opinion leaders in this field to identify and discuss the critical factors determining the success of current CKD pipelines and significantly impact the standard of care for this huge unmet medical need. \n \nBringing together leading experts from innovative biotechs\, large pharma\, academia and key service provider companies\, CKD3 will present comprehensive insight into the cutting edge progress of CKD drug development research. \nTo learn more and to register online\, visit https://ter.li/10so2k
URL:https://www.pharmajournalist.com/event/2nd-annual-ckd3-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190507
DTEND;VALUE=DATE:20190510
DTSTAMP:20260514T214546
CREATED:20190313T080024Z
LAST-MODIFIED:20190313T080024Z
UID:19944-1557187200-1557446399@www.pharmajournalist.com
SUMMARY:Extractables & Leachables USA 2019
DESCRIPTION:Extractables & Leachables USA brings together leading E&L experts and decision makers from across the supply chain to get the latest updates on regulations\, best practices\, safety compliance\, biocompatibility\, advancements in the sector\, working group updates\, and much more. Taking place May 7-9\, 2019\, at the Westin Arlington Gateway in Arlington\, Virginia – this event offers the unique opportunity to make new connections\, network with peers\, share new information\, and discuss the key topics\, trends\, and new industry developments that are affecting the E&L marketplace. Use code PHARM19 to SAVE 15% off the current ticket price!
URL:https://www.pharmajournalist.com/event/extractables-leachables-usa-2019/
LOCATION:Westin Arlington Gateway – 801 N Glebe Rd\, Arlington\, VA 22203\, United States
ORGANIZER;CN="Smithers Rapra":MAILTO:aszymanski@smithers.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190508
DTEND;VALUE=DATE:20190510
DTSTAMP:20260514T214546
CREATED:20181214T105212Z
LAST-MODIFIED:20181214T105212Z
UID:18835-1557273600-1557446399@www.pharmajournalist.com
SUMMARY:GLOBAL CLINICAL TRIALS CONNECT 2018 (Collaboration\, Innovation And Enhancing Quality In Clinical Trials )
DESCRIPTION:The  Global Clinical Trials Connect 2019 conference focuses on introducing pioneer technology\, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail\, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency. This conference will bring together the industry experts and leaders across pharmaceutical\, biotechnological and CRO’s for brainstorming on Case studies on innovation\, collaboration and existing clinical data to headway the Clinical Trials process. Ethical considerations are given in this context and for this RBM are beginning to extend its concepts in Quality Risk Management; clinical trial predictive models are accumulated by enterprises\, methodologies in trial design and many more.
URL:https://www.pharmajournalist.com/event/global-clinical-trials-connect-2018-collaboration-innovation-and-enhancing-quality-in-clinical-trials/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190515
DTEND;VALUE=DATE:20190517
DTSTAMP:20260514T214546
CREATED:20190114T083448Z
LAST-MODIFIED:20190123T091623Z
UID:19074-1557878400-1558051199@www.pharmajournalist.com
SUMMARY:SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
DESCRIPTION:The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019. \nThe global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%. \n \nInjectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently\, there has been a focus on novel drug delivery\, including needle-free injectors\, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually\, injectables were used for delivery of hormones\, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins\, including high viscosity and high volume. Self-administrative\, connected\, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices. \nThe benefits of attending: \nDeveloping on last year’s success\, this event assembles an international audience to include regulatory\, device design\, packaging and formulation professionals.  The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends\, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape. \nThis conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following: \n– Life cycle management for developing devices that are both user friendly and revenue effective\n– Device design considerations\n– Long acting injectables and bringing these therapeutics to market with case studies\n– Connected devices\, GDPR and cyber security programs\n– Developments in primary packaging\n– Growth in transdermal delivery and subcutaneous infusion devices\n– Digital health partnerships\n– Large volume patch pump innovation examples \nWho should attend \nExecutives\, Directors\, VPs\, Heads\, Principals\, Managers\, Scientists\, Researchers of: \n\nAutoinjectors\nWearables\nDevice Engineering\nHuman Factors\nCMC\nInjectables\nSterile Manufacturing\nPackaging\nRegulatory Affairs\n\nFeatured Speakers: \n\nBjorg K. Hunter\, Device Engineering Manager\, GSK\nMiranda Newbery\, Human Factors Consultant\, Inspired Usability\nBlake Green\, Regulatory Affairs Senior Manager\, Devices\, Amgen\nQuentin Le Masne\, Head of Engineering team – Electro-Medical / Drug Delivery Devices\, Merck\nVasco Filipe\, Formulation and Drug Process Development Section Head for Biologics\, Sanofi\nStephen Paboojian\, Senior Project Leader I for Device Development\, Novartis\nTom Lawrie-Fussey\, Digital Services Specialist\, Cambridge Design Partnership\nTerry Reed\, Director of Business development\, AstraZeneca\nJoel Richard\, Head of Technical and Pharmaceutical Operations\, MedinCell\n\n*Plus\, pre-conference workshops – 14th May 2019 \nEARLY-BIRD RATES: \n\nBOOK BY 31st JANUARY AND SAVE £400\nBOOK BY 28th FEBRUARY AND SAVE £200\nBOOK BY 29th MARCH AND SAVE £100\n\nLinkedIn: @SMi Pharma \nTwitter: @SMiPharm #SMi \nTo learn more about this event\, and to register online\, visit www.injectable-drug-delivery.com/pharmajwl
URL:https://www.pharmajournalist.com/event/injectable-drug-delivery-2019/
LOCATION:Copthorne Tara Hotel London Kensington\, Copthorne Tara Hotel London Kensington\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190522
DTSTAMP:20260514T214546
CREATED:20190108T101939Z
LAST-MODIFIED:20190108T103213Z
UID:18959-1558310400-1558483199@www.pharmajournalist.com
SUMMARY:Global Bioprocessing\, Bioanalytics and ATMP Manufacturing Congress
DESCRIPTION:This comprehensive two-day congress features 30 presentations given across four tracks. It will provide experts with an exceptional environment in which to examine the key developments occurring today. Topics covered includethe automation of vaccine formulations\, purification technologies\, T-cell manufacturing and glycoanalytic technologies.
URL:https://www.pharmajournalist.com/event/global-bioprocessing-bioanalytics-and-atmp-manufacturing-congress/
LOCATION:Dublin\, Ireland\, Hotel Riu Plaza The Gresham Dublin\, Dublin\, Ireland
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260514T214546
CREATED:20190108T102413Z
LAST-MODIFIED:20190108T102413Z
UID:18964-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Microbiome & Probiotics Series: Europe
DESCRIPTION:Part of the leading global microbiome and probiotics conference series\, the 2019 European event will bring together more than 400 industry\, academic\, and investment leaders to discuss the must cutting-edge microbiome and probiotics research\, challenges and opportunities in moving research towards commercialisation\, and potential partnerships and collaborations. \nFor the first time\, this event will be three days. As an attendee\, you will get more in-depth content on the key challenges and topics facing researchers and product developers\, and more time to establish partnerships. Hear from top scientists in the field\, meet willing investors and collaborators\, and learn about exciting new companies in the microbiome space. With ample networking time and interactive sessions like the roundtable discussions\, there will be many opportunities to broaden your connections.
URL:https://www.pharmajournalist.com/event/microbiome-probiotics-series-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260514T214546
CREATED:20190108T102702Z
LAST-MODIFIED:20190108T102702Z
UID:18969-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Plant Genomics and Gene Editing Congress: Europe
DESCRIPTION:Global Engage is pleased to announce the 7th Plant Genomics & Gene Editing Congress: Europe\, taking place 21st-22nd May 2019\, in Rotterdam\, The Netherlands. This event is part of our widely-regarded Plant Genomics Series which includes an Asian and US meeting each year. \nAttracting over 300 experts working in all areas of plant science\, this event will examine the latest in gene editing methods for plant genomics research. CRISPR/Cas9 case studies and the very best strategies for plant genome engineering will be presented by industry leaders\, experts\, and pioneering academics at the forefront of plant research. Developments in gene editing\, NGS\, and omic technologies will all be explored for crop trait development\, disease resistance\, epigenetics\, plant breeding\, and more. Tracks dedicated to plant & soil microbiomes\, and the importance of plant phenotyping in the context of bioinformatics challenges\, will encourage a holistic approach to plant research; the former will focus on identifying microbes to enhance crop productivity & disease resistance\, while the latter will showcase the best tools for overcoming bioinformatics bottlenecks\, applicable to plant research across the board. We will also be looking to examine the impact of the ECJ’s latest interpretation of GMO regulations\, and what this means for the future of gene editing research\, addressing issues such as how to navigate the new legislation\, and considering what alternative strategies & technologies there might be for progressing plant genomics.
URL:https://www.pharmajournalist.com/event/plant-genomics-and-gene-editing-congress-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T214546
CREATED:20190213T092120Z
LAST-MODIFIED:20190214T153920Z
UID:19511-1558310400-1558655999@www.pharmajournalist.com
SUMMARY:TIDES: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:TIDES is the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization. \n \n1000+ Oligonucleotide & Peptide Scientists and Executives\nFast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma\, biotechs\, academia and solution providers from North America\, Asia and Europe. \n90+ Exhibitors\nConnect with leading manufacturing\, technologies\, and service providers to drive your promising therapeutic towards commercial success. \n125+ Case Studies and New Data Presentations\nHear best practices\, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production. \nRegister now at www.TIDESEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/tides-oligonucleotide-peptide-therapeutics/
LOCATION:Manchester Grand Hyatt | San Diego\, CA
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190523
DTSTAMP:20260514T214546
CREATED:20181214T110222Z
LAST-MODIFIED:20181214T110356Z
UID:18840-1558396800-1558569599@www.pharmajournalist.com
SUMMARY:3rd Annual Digi-Tech Pharma 2019
DESCRIPTION:Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019)\, will provide a platform to all its participants an opportunity to interact\, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced\, new strategies\, case studies and use of innovative ideas in the field of Digital Pharma IT. Also\, to stay updated on the latest trends in digital\, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/3rd-annual-digi-tech-pharma-2019/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T214546
CREATED:20190206T125335Z
LAST-MODIFIED:20190206T125335Z
UID:19387-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:NDD Europe 2019
DESCRIPTION:Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics \n \nMultiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success. \nNDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration\, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers. \nWith 70+ thought-leaders converging at NDD Europe\, this will be an unrivalled opportunity for you to gain the latest scientific insights\, have your peers review your research and grow your collaborator network.
URL:https://www.pharmajournalist.com/event/ndd-europe-2019/
LOCATION:Hilton Paris La Defense\, 2 Place de la Défense\, 92800\, Puteaux\, France\, France
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T214546
CREATED:20190404T072211Z
LAST-MODIFIED:20190404T072453Z
UID:20182-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:5th Precision CRISPR Genome Editing Congress
DESCRIPTION:Designed with CRISPR experts from AstraZeneca\, AbbVie\, Broad Institute\, Casebia\, Merck\, Amgen and academics worldwide\, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery\, safety\, precision\, and efficiency to further optimize the relevant areas of drug discovery\, functional screening & CRISPR-based cell & gene therapy. \n \n\nLearn about how CRISPR is working in a clinical setting and unique approaches to gene therapy\nDiscover advances in disease modeling and strategies improving validation of human biology\nUnderstand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox\nExplore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases\nDiscover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline\nParticipate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR\n\nWith 100+ thought-leaders converging\, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network. \nTo learn more about this event\, visit https://ter.li/tjkmgn
URL:https://www.pharmajournalist.com/event/5th-precision-crispr-genome-editing-congress/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190525
DTSTAMP:20260514T214546
CREATED:20190118T101935Z
LAST-MODIFIED:20190118T101935Z
UID:19147-1558569600-1558742399@www.pharmajournalist.com
SUMMARY:RE•WORK Deep Learning in Healthcare Summit\, Boston
DESCRIPTION:The Deep Learning in Healthcare Summit is returning to the east coast for the annual event in Boston! Hear from healthcare industry leaders\, academics\, researchers\, and innovative startups working to advance deep learning technology and apply this within the health sector. Focusing on topics such as medical imaging\, diagnostics\, personalized medicine and how these are applied within pharmaceuticals\, patient care\, and health and wellbeing. The summit is a great way to discover the latest insights\, evaluate your position within the industry and learn how the impacts can affect yourself and your work and provides an opportunity to network with other valued members of the community. \nDiscount Code: MP20 
URL:https://www.pharmajournalist.com/event/re%e2%80%a2work-deep-learning-in-healthcare-summit-boston/
LOCATION:InterContinental® Boston\, 510 Atlantic Avenue\, Massachusetts 02210
ORGANIZER;CN="RE%E2%80%A2WORK":MAILTO:luke@re-work.co
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T214546
CREATED:20190213T123725Z
LAST-MODIFIED:20190213T124118Z
UID:19536-1558569600-1558655999@www.pharmajournalist.com
SUMMARY:Microbiome Invest
DESCRIPTION:Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors\, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
URL:https://www.pharmajournalist.com/event/microbiome-invest-2/
LOCATION:London (Venue TBC)
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190528
DTEND;VALUE=DATE:20190530
DTSTAMP:20260514T214546
CREATED:20190417T100847Z
LAST-MODIFIED:20190417T100847Z
UID:20361-1559001600-1559174399@www.pharmajournalist.com
SUMMARY:Healthcare Market Access & Pricing World Summit
DESCRIPTION:The 2nd annual Healthcare Market Access & Pricing Summit is the meeting place for the Healthcare Pricing\, Market Access\, Reimbursement\, HEOR\, and RWE community. \nSenior level experts from companies such as Abbott\, Merck\, Allergan\, and Johnson & Johnson among others will give you valuable insights through various interactive sessions. \nWith hot session topics like biosimilars\, orphan drugs and rare diseases\, this conference will provide a total and complete insight into the latest developments in the healthcare space\, may it be Pharma\, MedTech\, Biopharma or Biotech. \nJoin over 60+ healthcare professionals in May\, and book your ticket now!
URL:https://www.pharmajournalist.com/event/healthcare-market-access-pricing-world-summit/
LOCATION:NH Frankfurt Airport West Kelsterbacher Str. 19\, 65479 Germany
ORGANIZER;CN="Engaged Communications":MAILTO:sales@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190529
DTEND;VALUE=DATE:20190531
DTSTAMP:20260514T214546
CREATED:20180206T133206Z
LAST-MODIFIED:20190516T105109Z
UID:9281-1559088000-1559260799@www.pharmajournalist.com
SUMMARY:Skin Microbiome Congress
DESCRIPTION:Skin Microbiome Congress\nRevere Hotel Boston Common 200 Stuart St\, Boston\, MA 02116\, USA\n29 – 30 May\, 2019 \n“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!” – Mike Conti\, Solabia \n \n2018 saw the microbiome move to the forefront of over 300 industry leaders\, who came together to exchange ideas at our Global Skin Microbiome Congress Series\, the first dedicated congress focusing solely on Skin Microbiome. \nWith the microbiome set to be the biggest trend in skincare for 2019\, we are incredibly excited to bring our flagship congress back to Boston\, building on our success globally and connecting over 300 industry leaders. \nThis year\, we take a deep-dive into the two key areas critical for success in this in this evolving field\, with our 2 concurrent tracks of content. Track 1 will focus on developing a functional understanding of the microbiome\, whereas track 2 will be focusing on building a commercial viable business. \nDon’t miss the opportunity to join leading industry experts to explore next steps for skin microbiome research and development\, as well as commercialization. \nThe inaugural Skin Microbiome Congress in 2018 SOLD OUT\, don’t miss your chance to attend this year’s event! \nTo learn more about Skin Microbiome Congress\, and to register online\, visit www.skinmicrobiomecongress.com
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR